Smithwise and Catapult have joined teams to become Archimedic! Read More.

Cervical Cancer Screening Device for the Developing World

Though highly treatable, cervical cancer is the third most common cancer worldwide and is often fatal, with 80% of cases occurring in the developing world. This is due in part to a lack of effective screening programs.

Access to life-saving screenings is impeded for many women in developing countries by their remote location, lack of qualified screeners, and social stigma.

A team of researchers from the University of Pennsylvania worked with Archimedic to develop a low-cost cervical cancer screening device that can be used by a patient to capture images of her cervix for professional evaluation offsite. 




Medtech Leaders Trust Archimedic